Ballicules.com

Loxapine inhaled

ADASUVE

Pronunciation: LOX-a-peen (AD-a-soov)

Loxapine inhaled ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Loxapine inhaled ballicule
Loxapine inhaled ADASUVE mascot mnemonic cartoon
Visual mnemonic: Loxapine inhaled mascot
“Air to soothe”
Loxapine mascot: “Lotsa ping, Lotsa Tang”
Spooky mascot → antipsychotic

What it isInhaled loxapine (ADASUVE, 2012) — single-use Staccato inhaler, IV-like speed without a needle for acute agitation; REMS: bronchospasm risk, contraindicated in asthma/COPD.

Why this oneSame molecule and receptor pharmacology as the parent card — the formulation (and its label) is the difference.

What limits itClass warnings of the parent molecule apply unchanged.

Loxapine inhaled molecular structure (skeletal formula)
Molecular structure: Loxapine inhaled

FDA-approved for

FDA label

BOXED WARNING Bronchospasm (potential respiratory distress/arrest), available only via ADASUVE REMS; increased mortality in elderly with dementia-related psychosis.
FDA dosingPopulationStartTargetMax
Acute agitation associated with schizophrenia or bipolar I disorderAdults10 mg by oral inhalation, single dose10 mg per 24 h (single dose only)

Renal Undefined

Hepatic Undefined

Only a single dose within any 24-hour period

Instructions

Available strengths

Contraindications

Cautions

Adverse reactions

Pregnancy Third-trimester exposure risks extrapyramidal/withdrawal symptoms in neonates; data insufficient for birth-defect risk.

Lactation No human data; consider benefits of breastfeeding vs. maternal need and potential infant effects.

Cost

Loxapine inhaled (ADASUVE)
Strength#/mogeneric $/unitCostPlus
10 mgpowderper unitnot offered
NADAC is a voluntary CMS survey of what retail community pharmacies pay for the drugs they stock. Loxapine inhaled is dispensed outside retail pharmacies, so it rarely appears on surveyed invoices.

Other forms: Loxapine (LOXITANE)

⚠ BOXED WARNING

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger2 / 4
Weight-gain liability1 / 4
Sedation liability2 / 4
QT / Torsades1 / 4
Direct muscarinic antagonism1 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryC

Defining liabilityMetabolic effects, extrapyramidal symptoms/tardive dyskinesia and agent-specific QT or orthostatic risk.

Active metabolites

Open Loxapine inhaled in the interactive console ↗

Memory aids: interaction avatars

Loxapine inhaled Box: minimal PK interactions avatar mnemonic
Box: minimal PK interactions

Open Loxapine inhaled in the interactive console ↗